BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2832851)

  • 1. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled.
    de Nucci G; Gryglewski RJ; Warner TD; Vane JR
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2334-8. PubMed ID: 2832851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
    Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF.
    Clesham G; Parsaee H; Joseph S; McEwan JR; MacDermot J
    Cardiovasc Res; 1992 May; 26(5):513-7. PubMed ID: 1446322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells.
    White DG; Martin W
    Br J Pharmacol; 1989 Jul; 97(3):683-90. PubMed ID: 2547481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells.
    Richards JM; Gibson IF; Martin W
    Br J Pharmacol; 1991 Jan; 102(1):203-9. PubMed ID: 1646057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of captopril on the bradykinin-induced release of prostacyclin from guinea-pig lungs and bovine aortic endothelial cells.
    de Nucci G; Warner T; Vane JR
    Br J Pharmacol; 1988 Nov; 95(3):783-8. PubMed ID: 2850062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
    Gryglewski RJ; Moncada S; Palmer RM
    Br J Pharmacol; 1986 Apr; 87(4):685-94. PubMed ID: 3085757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-derived relaxing factor released from cultured cells: differentiation from nitric oxide.
    Dusting GJ; Read MA; Stewart AG
    Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):83-92. PubMed ID: 3271606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
    Martin W; White DG; Henderson AH
    Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture.
    Doni MG; Whittle BJ; Palmer RM; Moncada S
    Eur J Pharmacol; 1988 Jun; 151(1):19-25. PubMed ID: 3046956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells.
    Lückhoff A; Pohl U; Mülsch A; Busse R
    Br J Pharmacol; 1988 Sep; 95(1):189-96. PubMed ID: 3064851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-dependent relaxation is independent of arachidonic acid release.
    Milner PG; Izzo NJ; Saye J; Loeb AL; Johns RA; Peach MJ
    J Clin Invest; 1988 Jun; 81(6):1795-803. PubMed ID: 3133395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of prostacyclin, endothelium-derived relaxing factor and endothelin by freshly harvested cells attached to microcarrier beads.
    Kibira S; Dudek R; Narayan KS; Bing RJ
    Mol Cell Biochem; 1991 Nov; 108(1):75-84. PubMed ID: 1663210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells.
    D'Orléans-Juste P; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Apr; 96(4):920-6. PubMed ID: 2545298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The half-life of endothelium-derived relaxing factor released from bovine aortic endothelial cells in culture.
    Angus JA; Cocks TM
    J Physiol; 1987 Jul; 388():71-81. PubMed ID: 3498834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta.
    Bult H; Fret HR; Van den Bossche RM; Herman AG
    Br J Pharmacol; 1988 Dec; 95(4):1308-14. PubMed ID: 3064856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.